Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors

Table 2 Statistical analysis on circRNA comparisons

Comparison	N° circRNAs	N° circRNAs with p ≤ 0.05			N° circRNAs with p ≤ 0.05 and FDR ≤ 0.05
		Up	Down	Total	Up	Down	Total
GEP-NETs vs controls	5959	109	143	252	0	5	5
GEP-NETs: baseline vs follow-up
Patient #1	21908	8491	2943	11434	4280	1482	5762
Patient #2	21736	6238	3031	9269	0	0	0
Patient #3	24468	2996	3242	6238	0	0	0
Patient #4	22072	3129	8053	11182	1269	2333	3602
Patient #5	20893	3434	6590	10024	2397	3188	5585

Table shows the total number of circRNAs identified for the comparison GEP-NETs at baseline vs healthy donors and GEP-NETs at baseline vs early follow-up and the number of up and downregulated circRNAs with p < 0.05 and p < 0.05 + FDR < 0.05
Bold values refer to total number of circRNAs. Bold was used to graphically emphatize total values in the table

ISSN: 1479-5876